408 related articles for article (PubMed ID: 15340086)
1. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
Zhu B; Gulick T
Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
[TBL] [Abstract][Full Text] [Related]
2. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.
Zhu B; Ramachandran B; Gulick T
J Biol Chem; 2005 Aug; 280(31):28749-60. PubMed ID: 15834131
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.
Kang J; Gocke CB; Yu H
BMC Biochem; 2006 Feb; 7():5. PubMed ID: 16478538
[TBL] [Abstract][Full Text] [Related]
4. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.
Wu Z; Woodring PJ; Bhakta KS; Tamura K; Wen F; Feramisco JR; Karin M; Wang JY; Puri PL
Mol Cell Biol; 2000 Jun; 20(11):3951-64. PubMed ID: 10805738
[TBL] [Abstract][Full Text] [Related]
5. Functional regulatory regions of human transcription factor MEF2C.
Janson CG; Chen Y; Li Y; Leifer D
Brain Res Mol Brain Res; 2001 Dec; 97(1):70-82. PubMed ID: 11744164
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity.
Molkentin JD; Li L; Olson EN
J Biol Chem; 1996 Jul; 271(29):17199-204. PubMed ID: 8663403
[TBL] [Abstract][Full Text] [Related]
7. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
8. Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression.
Perry RL; Yang C; Soora N; Salma J; Marback M; Naghibi L; Ilyas H; Chan J; Gordon JW; McDermott JC
Mol Cell Biol; 2009 Jun; 29(12):3355-66. PubMed ID: 19364819
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C.
Molkentin JD; Black BL; Martin JF; Olson EN
Mol Cell Biol; 1996 Jun; 16(6):2627-36. PubMed ID: 8649370
[TBL] [Abstract][Full Text] [Related]
10. Post-translational control of the MEF2A transcriptional regulatory protein.
Ornatsky OI; Cox DM; Tangirala P; Andreucci JJ; Quinn ZA; Wrana JL; Prywes R; Yu YT; McDermott JC
Nucleic Acids Res; 1999 Jul; 27(13):2646-54. PubMed ID: 10373581
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
Sartorelli V; Huang J; Hamamori Y; Kedes L
Mol Cell Biol; 1997 Feb; 17(2):1010-26. PubMed ID: 9001254
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
Zhang M; Zhu B; Davie J
J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
[TBL] [Abstract][Full Text] [Related]
13. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.
Martin JF; Miano JM; Hustad CM; Copeland NG; Jenkins NA; Olson EN
Mol Cell Biol; 1994 Mar; 14(3):1647-56. PubMed ID: 8114702
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the MEF2 family of transcription factors by p38.
Zhao M; New L; Kravchenko VV; Kato Y; Gram H; di Padova F; Olson EN; Ulevitch RJ; Han J
Mol Cell Biol; 1999 Jan; 19(1):21-30. PubMed ID: 9858528
[TBL] [Abstract][Full Text] [Related]
15. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells.
Ridgeway AG; Wilton S; Skerjanc IS
J Biol Chem; 2000 Jan; 275(1):41-6. PubMed ID: 10617583
[TBL] [Abstract][Full Text] [Related]
16. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
Ma K; Chan JK; Zhu G; Wu Z
Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
[TBL] [Abstract][Full Text] [Related]
17. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.
Yang SH; Galanis A; Sharrocks AD
Mol Cell Biol; 1999 Jun; 19(6):4028-38. PubMed ID: 10330143
[TBL] [Abstract][Full Text] [Related]
18. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
Xu J; Gong NL; Bodi I; Aronow BJ; Backx PH; Molkentin JD
J Biol Chem; 2006 Apr; 281(14):9152-62. PubMed ID: 16469744
[TBL] [Abstract][Full Text] [Related]
19. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.
Kato Y; Zhao M; Morikawa A; Sugiyama T; Chakravortty D; Koide N; Yoshida T; Tapping RI; Yang Y; Yokochi T; Lee JD
J Biol Chem; 2000 Jun; 275(24):18534-40. PubMed ID: 10849446
[TBL] [Abstract][Full Text] [Related]
20. MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57.
Kobarg CB; Kobarg J; Crosara-Alberto DP; Theizen TH; Franchini KG
FEBS Lett; 2005 May; 579(12):2615-22. PubMed ID: 15862299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]